Author

Kausilia K. Krishnadath 1

1 AMC,Amsterdam,Netherlands

BARRETT’S ESOPHAGUS CELL OF ORIGIN DOES NOT DERIVE FROM CYTOKERATIN 5 EXPRESSING SQUAMOUS CELLS IN MICE.

Danielle Straub, Navtej Buttar, Paul Fockens, Kausilia K. Krishnadath

IDENTIFICATION OF THREE DISTINCT BIOLOGICAL SUBTYPES IN ESOPHAGEAL AND JUNCTIONAL ADENOCARCINOMA  BY RNA SEQUENCING

Sanne Hoefnagel, Brendon Scicluna, Silvia Calpe, Carmen del Sancho-Serra, Kausilia K. Krishnadath

Finding the bad Barrett's: Biomarkers

Kausilia K. Krishnadath

INHIBITION OF BMP2 AND BMP4 BY A NOVEL LLAMA-DERIVED NANOBODY SUSTAINS INTESTINAL STEM CELLS IN ORGANOID CULTURES

Silvia Calpe, Ana Correia, Cheryl Zimberlin, Jan Paul Medema, Kausilia K. Krishnadath

SPECIFIC BMP4 INHIBITION AS A POTENTIAL THERAPEUTIC STRATEGY FOR SMAD4 DEFECTIVE ESOPHAGEAL ADENOCARCINOMAS

Silvia Calpe, Matthew Read, Sanne Hoefnagel, Maria del carmen Sancho Serra, Danielle Straub, Ana Correia, Nick Clemons, David Liu, Wayne Phillips, Kausilia K. Krishnadath

MULTI LAYERED EPITHELIUM INDUCED BY BILE AT THE SQUAMO-COLUMNAR JUNCTION IN MICE ORIGINATES FROM SQUAMOUS AND COLUMNAR CELLS.

Danielle Straub, Chun Ming Chen, Paul Fockens, Kausilia K. Krishnadath

TUMOR ASSOCIATED MACROPHAGES AS NOVEL TARGETS FOR IMMUNOTHERAPY IN ESOPHAGEAL ADENOCARCINOMA  

Silvia Calpe, Sanne Hoefnagel, Souhailla Bouchmal, Carmen del Sancho-Serra, Danielle Straub, Kausilia K. Krishnadath

REMODELING BARRETT’S METAPLASIA IN A NOVEL IN VIVO HUMANORGANOID MODEL

Ana Correia, Matthew Read, Silvia Calpe, Nicholas Clemons, David Liu, Cuong Duong, Wayne Phillips, Kausilia K. Krishnadath

Upper GI cancer

Kausilia K. Krishnadath

THE SURF TRIAL PRE-ASSESSMENT COHORT: SPATIAL EXTENT OF LOW-GRADE DYSPLASIA AND EXTENT OF AGREEMENT BETWEEN EXPERT PATHOLOGISTS ARE ASSOCIATED WITH RISK OF MALIGNANT PROGRESSION

Lucas Duits, Nadine Phoa, T. Pham, F. Kate, Cornelis (Kees) A Seldenrijk, G. Offerhaus, Kausilia K. Krishnadath, Jan G. P. Tijssen

Item 1 - 10 / 15
1
2
We use cookies in order to provide you with a better browsing experience. This includes third-party cookies for traffic analyzation purposes. See here for more information.
OK